V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 190007074 | 190005843 | 1.58 | 94 | Curative (C) | 2017-11-09 | 2017-11-12 | NIVOLUMAB | 02 | N | PACLITAXEL | 101476057 |
| 190007088 | 190005844 | 1.69 | 51.9 | null | null | 2019-04-02 | EW EuroEwing 2012 Arm A VAI | 02 | N | CABOZANTINIB | 100680147 |
| 190007094 | 190005845 | 1.83 | 58 | Neo-adjuvant (N) | 2016-03-12 | 2016-03-28 | OST Euramos 1 Closed Trial - IE | 02 | N | CISPLATIN + ETOPOSIDE | 101125341 |
| 190007102 | 190005847 | null | 68.7 | null | 2017-06-01 | 2017-06-16 | OST Euramos 1 Closed Trial - IE | 02 | N | DACARBAZINE | 100863813 |
| 190007113 | 190005848 | 1.65 | 42.9 | Palliative (P) | 2018-02-16 | 2018-03-05 | CABOZANTINIB | 01 | N | GEMCITABINE | 101195531 |
| 190007117 | 190005849 | 1.8 | 95.6 | Palliative (P) | 2017-09-15 | 2018-05-08 | Cisplatin + Radiotherapy | null | null | FLUOROURACIL + MITOMYCIN + RT | 101406096 |
| 190007136 | 190005850 | 1.8 | 78 | Curative (C) | 2019-08-06 | 2019-08-08 | Liposomal Doxorubicin 40mg/m2 | 02 | Y | DOCETAXEL | 100178389 |
| 190007146 | 190005851 | null | 89.7 | Palliative (P) | 2016-02-14 | 2016-03-27 | Cisplatin + Doxorubicin | 01 | N | OXALIPLATIN + MDG | 100449157 |
| 190007151 | 190005852 | 1.8 | 76 | Adjuvant (A) | 2021-01-03 | 2021-04-13 | Cetuximab + FLUOROURACIL + OXALIPLATIN | 02 | N | GEMCITABINE | 101632479 |
| 190007156 | 190005853 | 1.71 | 53.9 | Curative (C) | 2021-05-02 | 2021-05-17 | EW EuroEwing 2012 Arm B VDC/IE | 02 | N | CETUXIMAB + IRINOTECAN + MDG | 101193618 |
| 190007158 | 190005854 | 1.81 | 97.6 | null | 2022-05-17 | 2022-05-17 | VAC | null | null | NIVOLUMAB | 100600344 |
| 190007162 | 190005855 | 1.71 | 82.1 | Curative (C) | 2019-06-26 | 2019-06-28 | DHAP | 02 | null | ATEZOLIZUMAB | 101172818 |
| 190007166 | 190005856 | 1.81 | 53.75 | Curative (C) | 2017-12-28 | 2017-12-29 | Carboplatin AUC 6 - 10 | null | null | CARBOPLATIN | 100421778 |
| 190007183 | 190005857 | null | 74.45 | null | 2020-03-30 | 2020-04-08 | OST Euramos 1 Closed Trial - AP | 02 | N | CAPECITABINE | 101677202 |
| 190007184 | 190005858 | null | 99.7 | 03 | 2022-01-15 | 2022-02-11 | STS Rhabdo RMS 2005 Vin Cyclo | 02 | Y | ICON TRIAL | 101748547 |
| 190007192 | 190005859 | 0 | 38.4 | Curative (C) | 2021-02-21 | 2021-03-28 | MAP | 2 | null | CABOZANTINIB | 100554476 |
| 190007201 | 190005860 | 1.78 | 88.3 | Adjuvant (A) | null | 2016-07-15 | Carboplatin AUC 2 - 5 | null | null | CARBOPLATIN | 101212854 |
| 190007209 | 190005861 | 1.78 | 68.7 | Palliative (P) | null | 2017-09-21 | EW EuroEwing 2012 Arm B VDC/IE | null | null | CISPLATIN + CAPECITABINE + EPIRUBICIN | 101138951 |
| 190007224 | 190005862 | 1.82 | 53 | Palliative (P) | 2019-06-19 | 2019-06-20 | Cisplatin + Radiotherapy | 02 | N | CISPLATIN | 101541594 |
| 190007240 | 190005863 | 0 | 37.4 | Palliative (P) | 2019-08-10 | 2019-10-25 | Doxorubicin + Olaratumab | 02 | N | FLUOROURACIL + IRINOTECAN | 101621871 |
| 190007243 | 190005864 | 1.58 | 65.1 | Palliative (P) | 2017-10-16 | 2017-10-25 | CARBOPLATIN + PACLITAXEL | 02 | Y | CARBOPLATIN + PACLITAXEL | 100539888 |
| 190007244 | 190005865 | 1.83 | 90 | Curative (C) | 2021-08-31 | 2021-09-13 | Cisplatin | null | null | CISPLATIN | 100052913 |
| 190007250 | 190005866 | 1.79 | null | Palliative (P) | 2020-12-11 | 2020-12-11 | CAPECITABINE + CARBOPLATIN | 01 | N | ABEMACICLIB + FULVESTRANT | 100855440 |
| 190007260 | 190005867 | null | 103.8 | Curative (C) | null | 2017-09-12 | Liposomal Doxorubicin 40mg/m2 | null | null | LANREOTIDE | 100943121 |
| 190007274 | 190005868 | 1.77 | 84.1 | null | 2017-06-12 | 2017-12-13 | OST Euramos 1 Closed Trial - M | 02 | N | ATEZOLIZUMAB | 101239029 |
| 190007279 | 190005869 | 1.64 | 75.3 | null | 2020-05-28 | 2020-06-03 | Paclitaxel (2 or 3 weekly) | Y | N | CAPECITABINE + IRINOTECAN | 100632624 |
| 190007286 | 190005870 | 1.68 | 50 | null | 2016-07-07 | 2016-07-07 | Ifosfamide | N | Y | EVEROLIMUS | 100927376 |
| 190007302 | 190005871 | 1.87 | 88 | Palliative (P) | 2018-06-03 | 2018-06-17 | Cisplatin 7 day | 1 | N | CISPLATIN | 100186441 |
| 190007306 | 190005872 | 1.56 | 66.15 | Palliative (P) | null | 2020-09-11 | OCTREOTIDE | null | null | CARBOPLATIN + CYCLOPHOSPHAMIDE + ETOPOSIDE + PACLITAXEL | 100791055 |
| 190007307 | 190005873 | 1.71 | 102 | Curative (C) | 2018-11-27 | 2018-12-20 | PACLITAXEL | 02 | Y | CISPLATIN + DOCETAXEL + FLUOROURACIL | 101234427 |
| 190007313 | 190005874 | 1.8 | 80.7 | null | 2020-03-26 | 2020-04-20 | MAP | 02 | null | CISPLATIN + FLUOROURACIL | 100439831 |
| 190007323 | 190005875 | 1.52 | 71.1 | Palliative (P) | 2021-08-07 | 2021-09-10 | null | 01 | N | CARBOPLATIN + VINORELBINE | 100050738 |
| 190007331 | 190005876 | 1.6 | 56.3 | null | null | 2016-11-19 | GemCarbo Days 1+8 | 02 | N | FLUOROURACIL + IRINOTECAN | 100832363 |
| 190007342 | 190005877 | 1.9 | 87.6 | null | 2019-04-05 | 2019-06-04 | STS Rhabdomyosarcoma RMS 2005 IVA | 02 | null | CISPLATIN + FLUOROURACIL | 100474435 |
| 190007367 | 190005878 | 1.81 | 74.4 | Curative (C) | 2016-08-08 | 2016-08-11 | Capecitabine | 02 | N | CARBOPLATIN + RT | 100130976 |
| 190007369 | 190005879 | 1.59 | 91.8 | Neo-adjuvant (N) | null | 2020-08-18 | STS Non-Rhabdo EpSSG 2005 VDCy | N | N | NIVOLUMAB | 100127421 |
| 190007377 | 190005880 | 1.62 | 67.6 | Adjuvant (A) | 2017-11-27 | 2018-05-21 | EURAMOS TRIAL | 02 | N | GEMCITABINE | 101502456 |
| 190007383 | 190005881 | 1.62 | 26.1 | null | 2017-02-10 | 2017-02-10 | FLUOROURACIL + IRINOTECAN | 02 | N | NIVOLUMAB | 100059284 |
| 190007387 | 190005882 | 1.88 | 62.5 | 03 | 2020-10-26 | 2020-10-28 | CARBOPLATIN + GEMCITABINE | 02 | null | LANREOTIDE | 100051375 |
| 190007398 | 190005883 | 1.58 | 43.6 | Curative (C) | 2016-07-03 | 2016-07-29 | CARBOPLATIN + GEMCITABINE | 02 | N | DOCETAXEL | 100642019 |
| 190007402 | 190005884 | 1.74 | 78.5 | Adjuvant (A) | 2015-04-03 | 2016-08-10 | Cisplatin | 02 | null | CISPLATIN | 100907940 |
| 190007410 | 190005885 | 0 | 57.5 | Adjuvant (A) | 2017-08-13 | 2018-01-05 | Carboplatin AUC 2 - 5 | 02 | Y | CARBOPLATIN | 101493102 |
| 190007411 | 190005886 | 1.76 | 29.5 | Palliative (P) | 2021-01-06 | 2021-01-11 | CARBOPLATIN | 02 | N | CARBOPLATIN | 100663253 |
| 190007429 | 190005887 | null | 84.55 | Neo-adjuvant (N) | 2016-09-16 | 2016-10-06 | CYCLO + DOXORUBICIN + VINCRISTINE | 02 | Y | FLUOROURACIL + IRINOTECAN | 101061738 |
| 190007433 | 190005888 | 0 | 63.1 | Palliative (P) | 2022-03-25 | 2022-03-30 | CAPECITABINE + OXALIPLATIN | 02 | Y | BLEOMYCIN + CISPLATIN + ETOPOSIDE + PACLITAXEL | 100337818 |
| 190007440 | 190005889 | 1.68 | 65.9 | Curative (C) | 2016-06-20 | 2016-07-11 | Doxorubicin + Olaratumab | 01 | null | TOPOTECAN | 101535088 |
| 190007446 | 190005890 | 1.75 | 72.2 | Palliative (P) | 2018-10-16 | 2018-10-25 | CISPLATIN + GEMCITABINE | 02 | N | PACLITAXEL | 101122694 |
| 190007452 | 190005891 | 0 | 63.3 | Palliative (P) | null | 2013-10-12 | EURAMOS TRIAL | null | null | CAPECITABINE + OXALIPLATIN | 101061886 |
| 190007453 | 190005892 | 1.64 | 92.6 | null | null | 2016-12-30 | Etoposide oral | null | null | OCTREOTIDE | 100432894 |
| 190007469 | 190005894 | 1.6 | 55 | 03 | 2019-11-17 | 2019-12-23 | CARBOPLATIN | 02 | N | CARBOPLATIN | 101202023 |